Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 2607

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 2607
---
 inputs (Level 3) is
as follows for the year ended December 31, 2023: 

    Bridge Shares  
    Warrants  
    Convertible Notes Payable  
    Contingent Milestone Payment  
    Total 
  
    Derivative liabilities – December 31, 2022 
    $834,352  
    $578,164  
    $81,684  
    $-  
    $1,494,200 
  
    Change in fair value 
     13,798  
     (15,320) 
     (1,312) 
     -  
     (2,834)
  
    Fair value at commitment date 
     680,276  
     274,449  
     -  
     -  
     954,725 
  
    Change in fair value prior to conversion or reclassification 
     (105,790) 
     1,455  
     (45,207) 
     -  
     (149,542)
  
    Conversion of convertible promissory notes 
     (1,422,636) 
     -  
     (35,165) 
     -  
     (1,457,801)
  
    Reclassification of warrants to equity 
     -  
     (838,748) 
     -  
     -  
     (838,748)
  
    Recognition of contingent milestone liability 
     -  
     -  
     -  
     2,117,142  
     2,117,142 
  
    Change in fair value 
     -  
     -  
     -  
     189,654  
     189,654 
  
    Derivative liabilities - December 31, 2023 
    $-  
    $-  
    $-  
    $2,306,796  
    $2,306,796 

F-28

Changes in the fair value of derivative liabilities
are included in other income (expense) in the accompanying consolidated statements of operations and comprehensive loss. During the years
ended December 31, 2024 and 2023, the Company recorded a net gain (loss) on the change in the fair of derivative liabilities of $1,665,966